Company Description
Nature's Sunshine Products manufactures and markets through direct sales encapsulated and tableted herbal products, high quality natural vitamins, and other complementary products. In addition to the United States, the Company has operations in Japan, Mexico, Central America, South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the United Kingdom, Columbia, Brazil, Thailand, Israel, Singapore, Malaysia, Indonesia, the Philippines, Australia, Hong Kong, Taiwan, Russia, Ukraine, Latvia, Lithuania, Kazakhstan, Mongolia, Belarus, China, Poland, Germany, Austria, Norway, Sweden, the Czech Republic and the Netherlands. The Company also has exclusive distribution agreements with selected companies in Argentina, Australia, Chile, New Zealand, and Norway.
Financials, Fundamental Metrics & Ratios
| Revenue (Most Recent Fiscal Year) |
$454.36M |
| Net Income (Most Recent Fiscal Year) |
$7.70M |
| PE Ratio (Current Year Earnings Estimate) |
-- |
| PE Ratio (Trailing 12 Months) |
25.92 |
| PEG Ratio (Long Term Growth Estimate) |
-- |
| Price to Sales Ratio (Trailing 12 Months) |
0.61 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) |
1.68 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) |
12.24 |
| Pre-Tax Margin (Trailing 12 Months) |
4.57% |
| Net Margin (Trailing 12 Months) |
2.22% |
| Return on Equity (Trailing 12 Months) |
6.98% |
| Return on Assets (Trailing 12 Months) |
4.63% |
| Current Ratio (Most Recent Fiscal Quarter) |
2.41 |
| Quick Ratio (Most Recent Fiscal Quarter) |
1.50 |
| Debt to Common Equity (Most Recent Fiscal Quarter) |
0.00 |
| Inventory Turnover (Trailing 12 Months) |
2.08 |
| Book Value per Share (Most Recent Fiscal Quarter) |
$9.11 |
| Earnings per Share (Most Recent Fiscal Quarter) |
-- |
| Earnings per Share (Most Recent Fiscal Year) |
-- |
| Diluted Earnings per Share (Trailing 12 Months) |
$0.53 |